SEPTInvestingStart Free

GSK 6-K: Insider sale planned

GSK

Filed with the SEC on · accession 0001654954-26-009712

GSK filed a 6-K (foreign company report) with the SEC on Nov 12, 2026. How foreign companies listed in the US report news and events — like an 8-K for them. The stock moved +0.5% by the first close after the filing.

Summary of the filing

GSK disclosed that several PDMRs, including CFO Julie Brown and other executives, acquired small numbers of ordinary shares (12 shares each) under the Company's Share Reward Plan at £19.3453 per share on November 10, 2026.

For details, click here →How to read a 6-K →

Key details

Aggregate shares acquired by each PDMRGBP 12
Price per ordinary shareGBP 19
IssuerGSK plc
Ceo, viiv healthcare and president, global healthLynn Baxter
Chief financial officerJulie Brown
President, corporate developmentDavid Redfern
President, global supply chainRegis Simard
President, europeJames Strenner
President, global affairsPhilip Thomson

How GSK stock reacted

Close before

$50.60

Nov 11, 2026

First close after

+0.50%

$50.85

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for GSK, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for GSK?

Click here

Frequently asked questions

What did GSK file with the SEC on Nov 12, 2026?

GSK filed a 6-K (Insider sale planned). GSK disclosed that several PDMRs, including CFO Julie Brown and other executives, acquired small numbers of ordinary shares (12 shares each) under the Company's Share Reward Plan at £19.3453 per share on November 10, 2026.

How do I read a 6-K?

How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.

How did GSK stock react to this filing?

GSK closed at $50.60 before the filing and $50.85 on Nov 12, 2026 (+0.50%).

Other GSK SEC filings

Get alerts when GSK files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
GSK overviewGSK analysisGSK newsLatest SEC filings